Temporary space provider WillScot (NASDAQ:WSC) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4.7% year on year to
Infrastructure consulting firm NV5 Global (NASDAQ:NVEE) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.1% year
Medical technology company Hologic (NASDAQ:HOLX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 1.2% year on year to $1.01
Scientific consulting firm Exponent (NASDAQ:EXPO) announced better-than-expected revenue in Q1 CY2025, with sales up 6% year on year to $145.5 million.
Medical device company LeMaitre Vascular (NASDAQ:LMAT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12% year on
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 20.3%
Outerwear manufacturer Columbia Sportswear (NASDAQ:COLM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.1% year on year to $778.5
Digital transformation consultancy Grid Dynamics (NASDAQ:GDYN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 25.8%
US stocks likely hit a peak relative to the rest of global markets on Christmas Eve last year, Jefferies' top stock strategist said.
Medical device company DexCom (NASDAQ:DXCM) announced better-than-expected revenue in Q1 CY2025, with sales up 12.5% year on year to $1.04 billion. The
